Hylogomphus geminatus

Hylogomphus geminatus, the twin-striped clubtail, is a species of dragonfly in the family Gomphidae. It is endemic to the southeastern United States, and is found in small rivers and streams.[2][3][4]

Hylogomphus geminatus

Least Concern  (IUCN 3.1)[1]
Scientific classification
Kingdom: Animalia
Phylum: Arthropoda
Class: Insecta
Order: Odonata
Infraorder: Anisoptera
Family: Gomphidae
Genus: Hylogomphus
Species:
H. geminatus
Binomial name
Hylogomphus geminatus
(Carle, 1979)
Synonyms

Gomphus geminatus Carle, 1979

Hylogomphus geminatus was recently considered a member of the genus Gomphus, but in 2017 it became a member of the genus Hylogomphus when Hylogomphus was elevated from subgenus to genus rank.[5]

The IUCN conservation status of Hylogomphus geminatus is "LC", least concern, with no immediate threat to the species' survival. The population is stable. The IUCN status was reviewed in 2018. From 1986 to 1994 the species was assessed as "rare", was "lower risk/near threatened" in 1996, and "near threatened" in 2007. Hylogomphus geminatus has been found in about 20 locations in four states, each with a population of hundreds to thousands.[1]

Sources
  1. "Hylogomphus geminatus Red List status". IUCN Red List of Threatened Species. Retrieved 2018-08-18.
  2. "Hylogomphus geminatus Species Information". BugGuide.net. Retrieved 2018-08-18.
  3. "Odonata Central". Retrieved 2018-08-18.
  4. "World Odonata List". Slater Museum of Natural History, University of Puget Sound. 2018. Retrieved 2018-08-18.
  5. Ware, Jessica L.; Pilgrim, Erik; May, Michael L.; Donnelly, Thomas W.; et al. (2017). "Phylogenetic relationships of North American Gomphidae and their close relatives". Systematic Entomology. 42: 347–358. doi:10.1111/syen.12218. PMC 6104399. PMID 30147221.


gollark: I, for one, am using my atoms for nonpaperclip purposes and somewhat need them.
gollark: So you're arguing that the marginal value of a vaccine to everyone isn't great because it does not get substantially closer to eradication?
gollark: And?
gollark: The effectiveness in general scales with how many people have it and how good the vaccines are individually. We want to maximize that. So... it's sensible to reduce one factor because the other is lower?!
gollark: This is a... very bizarre argument?
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.